
This activity is supported by an Educational Grant from:
GILEAD
Powered by:

Epidemiology of HIV:
Changing Patterns of Infection and the Status of the HIV Care Cascade
John T. Brooks, MD
HIV Treatment Guidelines:
Choices in Patients with Liver Disease
Roy Gulick, MD, MPH
Epidemiology of Liver Disease in HIV:
Trends in Viral Hepatitis, NAFLD and HCC
Stuart C. Gordon, MD
Scoring Systems for Research in Liver Pathology
David E. Kleiner, MD, PhD
Mechanisms of Liver Injury Relevant to the HIV-infected Patient
Raymond T. Chung, MD
Immune reconstitution in HIV and the effect on HCV and HBV T cell repertoire
Kyong-Mi Chang, MD
NASH/ASH and Liver Injury in HIV-Infected Patients, Mechanisms and Solutions
Gyongyi Szabo, MD, PhD
The Microbiome, Gut Translocation, Immune Activation and Cardiovascular Disease in HIV:
The Central Role of the Liver
Phyllis C. Tien, MD
HCV/HIV Treatment with Oral Combination Therapies
Kristen M. Marks, MD
Immune Checkpoint Inhibitors for HIV, HCV and HBV infections
Shyam Kottilil, MD, Ph.D.
Hepatitis Delta Therapeutic Prospects in HIV Patients
Vincent Soriano
Barriers to Hepatitis C Care in the HIV-Infected Population in the U.S.
Camilla S. Graham, MD, MPH
HIV and Viral Hepatitis in the CORRECTIONAL system
Anne Spaulding, MP, MPH
HCC in HIV:
Screen More or Differently?
Marion Peters, MD
Vulnerability of Appalachia to Rapid Dissemination of HCV/HIV Infections
John T. Brooks, MD
Alcohol misuse and HIV outcomes among PLWH:
Epidemiology and Treatment
Geetanjali Chander, MD, MPH
Cocaine Use, Liver Function and Fibrosis
Marianna Baum, PhD, MS
Treatment of HCV in HCV/HIV and HCV Monoinfected Injection Drug Users
Andrew Aronsohn, MD
Modeling Harm Interventions To Prevent HIV and HCV Transmission Among PWID, HIV-Infected MSM, and Incarcerated Populations
Natasha Martin, DPhil
HIV, Hepatitis C and Psychiatric Co-morbities
Glen Treisman, MD, PhD
NIH Research Agenda Update
Jag H. Khalsa, MS, PhD
HIV & Liver Disease 2016:
Wrap Up
Kenneth E. Sherman, MD, PhD